1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders
(
- Contribution to journal › Article
- 2020
-
Mark
Alcohol Consumption and Risk of Parkinson's Disease : Data from a Large Prospective European Cohort
(
- Contribution to journal › Article
- 2019
-
Mark
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(30). p.15226-15235(
- Contribution to journal › Article
-
Mark
Low prevalence of known pathogenic mutations in dominant PD genes : A Swedish multicenter study
(
- Contribution to journal › Article
-
Mark
General and abdominal adiposity and the risk of Parkinson's disease : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Exploring causality of the association between smoking and Parkinson's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Blood-based NfL : A biomarker for differential diagnosis of parkinsonian disorder
(
- Contribution to journal › Article
- 2016
-
Mark
Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study
(
- Contribution to journal › Article
- 2013
-
Mark
Retigabine as add-on treatment of refractory epilepsy– a cost-utility study in a swedish setting
(
- Contribution to journal › Article